Willenbring H - Search Results

1

Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.

Poremba C, Willenbring H, Hero B, Christiansen H, Schäfer KL, Brinkschmidt C, Jürgens H, Böcker W, Dockhorn-Dworniczak B. Poremba C, et al. Among authors: willenbring h. Ann Oncol. 1999 Jun;10(6):715-21. doi: 10.1023/a:1008333500733. Ann Oncol. 1999. PMID: 10442195 Free article.

2

Telomerase activity in human proliferative breast lesions.

Poremba C, Böcker W, Willenbring H, Schäfer KL, Otterbach F, Bürger H, Diallo R, Dockhorn-Dworniczak B. Poremba C, et al. Among authors: willenbring h. Int J Oncol. 1998 Mar;12(3):641-8. doi: 10.3892/ijo.12.3.641. Int J Oncol. 1998. PMID: 9472105

3

Molecular genetic analysis and human chorionic gonadotropin stimulation tests in the diagnosis of prepubertal patients with partial 5 alpha-reductase deficiency.

Hiort O, Willenbring H, Albers N, Hecker W, Engert J, Dibbelt L, Sinnecker GH. Hiort O, et al. Among authors: willenbring h. Eur J Pediatr. 1996 Jun;155(6):445-51. doi: 10.1007/BF01955179. Eur J Pediatr. 1996. PMID: 8789759

4

Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency.

Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zöllner A, Struve D. Hiort O, et al. Among authors: willenbring h. J Clin Endocrinol Metab. 1996 Sep;81(9):3415-8. doi: 10.1210/jcem.81.9.8784107. J Clin Endocrinol Metab. 1996. PMID: 8784107

5

Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene.

Homberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E, Koch HG. Homberger A, et al. Among authors: willenbring h. Eur J Hum Genet. 2000 Sep;8(9):725-9. doi: 10.1038/sj.ejhg.5200522. Eur J Hum Genet. 2000. PMID: 10980581

6

Argininosuccinate lyase (ASL) deficiency: mutation analysis in 27 patients and a completed structure of the human ASL gene.

Linnebank M, Tschiedel E, Häberle J, Linnebank A, Willenbring H, Kleijer WJ, Koch HG. Linnebank M, et al. Among authors: willenbring h. Hum Genet. 2002 Oct;111(4-5):350-9. doi: 10.1007/s00439-002-0793-4. Epub 2002 Aug 14. Hum Genet. 2002. PMID: 12384776

7

Reply.

Laemmle A, Häberle J, Willenbring H. Laemmle A, et al. Among authors: willenbring h. Hepatology. 2022 Apr;75(4):1059-1060. doi: 10.1002/hep.32290. Epub 2022 Jan 26. Hepatology. 2022. PMID: 34935158 Free article. No abstract available.

8

Aquaporin 9 induction in human iPSC-derived hepatocytes facilitates modeling of ornithine transcarbamylase deficiency.

Laemmle A, Poms M, Hsu B, Borsuk M, Rüfenacht V, Robinson J, Sadowski MC, Nuoffer JM, Häberle J, Willenbring H. Laemmle A, et al. Among authors: willenbring h. Hepatology. 2022 Sep;76(3):646-659. doi: 10.1002/hep.32247. Epub 2021 Dec 18. Hepatology. 2022. PMID: 34786702 Free PMC article.

9

A ZFN/piggyBac step closer to autologous liver cell therapy.

Mattis AN, Willenbring H. Mattis AN, et al. Among authors: willenbring h. Hepatology. 2012 Jun;55(6):2033-5. doi: 10.1002/hep.25715. Hepatology. 2012. PMID: 22422378 No abstract available.

10

The MAP3K TAK1: a chock block to liver cancer formation.

Malato Y, Willenbring H. Malato Y, et al. Among authors: willenbring h. Hepatology. 2010 Oct;52(4):1506-9. doi: 10.1002/hep.23878. Hepatology. 2010. PMID: 20879030 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters